Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 31.3% – Should You Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price traded down 31.3% during mid-day trading on Thursday . The stock traded as low as C$0.14 and last traded at C$0.17. 1,643,425 shares changed hands during mid-day trading, an increase of 198% from the average session volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Price Performance

The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The business’s 50 day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.07. The stock has a market capitalization of C$23.01 million, a P/E ratio of -16.50 and a beta of 0.32.

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.